BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 20616688)

  • 21. Identification of optical density ratios in subretinal fluid as a clinically relevant biomarker in exudative macular disease.
    Ahlers C; Golbaz I; Einwallner E; Dunavölgyi R; Malamos P; Stock G; Pruente C; Schmidt-Erfurth U
    Invest Ophthalmol Vis Sci; 2009 Jul; 50(7):3417-24. PubMed ID: 19168899
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intravitreal triamcinolone as an adjunct to standard laser therapy in coexisting high-risk proliferative diabetic retinopathy and clinically significant macular edema.
    Mirshahi A; Shenazandi H; Lashay A; Faghihi H; Alimahmoudi A; Dianat S
    Retina; 2010 Feb; 30(2):254-9. PubMed ID: 20057344
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic significance of delayed structural recovery after macular hole surgery.
    Christensen UC; Krøyer K; Sander B; Larsen M; la Cour M
    Ophthalmology; 2009 Dec; 116(12):2430-6. PubMed ID: 19744721
    [TBL] [Abstract][Full Text] [Related]  

  • 24. BASELINE SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHIC HYPERREFLECTIVE FOCI AS A PREDICTOR OF VISUAL OUTCOME AND RECURRENCE FOR CENTRAL SEROUS CHORIORETINOPATHY.
    Lee H; Lee J; Chung H; Kim HC
    Retina; 2016 Jul; 36(7):1372-80. PubMed ID: 26702841
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Subretinal dot-like precipitates and yellow material in central serous chorioretinopathy.
    Maruko I; Iida T; Ojima A; Sekiryu T
    Retina; 2011 Apr; 31(4):759-65. PubMed ID: 21052035
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Factors correlated with postoperative visual acuity after vitrectomy and internal limiting membrane peeling for myopic foveoschisis.
    Kumagai K; Furukawa M; Ogino N; Larson E
    Retina; 2010 Jun; 30(6):874-80. PubMed ID: 20094010
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transpupillary thermotherapy for subfoveal leaks in central serous chorioretinopathy.
    Shukla D; Kolluru C; Vignesh TP; Karthikprakash S; Kim R
    Eye (Lond); 2008 Jan; 22(1):100-6. PubMed ID: 16732205
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Angiographic and Tomographic Prognostic Factors of Chronic Central Serous Chorioretinopathy Treated with Half-Dose Photodynamic Therapy.
    Chung CY; Chan YY; Li KKW
    Ophthalmologica; 2018; 240(1):37-44. PubMed ID: 29566395
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Does microperimetry have a prognostic value in central serous chorioretinopathy?
    Roisman L; Ribeiro JC; Fechine FV; Lavinsky D; Moraes N; Campos M; Farah ME
    Retina; 2014 Apr; 34(4):713-8. PubMed ID: 23975001
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Significant improvements in near vision, reading speed, central visual field and related quality of life after ranibizumab treatment of wet age-related macular degeneration.
    Frennesson C; Nilsson UL; Peebo BB; Nilsson SE
    Acta Ophthalmol; 2010 Jun; 88(4):420-5. PubMed ID: 19678811
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Measurement of macular edema in retinal vein occlusion using optical coherence tomography and its visual prognosis].
    Zhang HR; Wang X; Lu XR; Yang YF; Liu F
    Zhonghua Yan Ke Za Zhi; 2005 Oct; 41(10):910-6. PubMed ID: 16271177
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Infrared fundus autofluorescence and central serous chorioretinopathy.
    Sekiryu T; Iida T; Maruko I; Saito K; Kondo T
    Invest Ophthalmol Vis Sci; 2010 Oct; 51(10):4956-62. PubMed ID: 20435599
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Morphologic changes in acute central serous chorioretinopathy evaluated by fourier-domain optical coherence tomography.
    Fujimoto H; Gomi F; Wakabayashi T; Sawa M; Tsujikawa M; Tano Y
    Ophthalmology; 2008 Sep; 115(9):1494-500, 1500.e1-2. PubMed ID: 18394706
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early laser photocoagulation treatment as an option in central serous chorioretinopathy.
    Sturm V
    Ophthalmic Surg Lasers Imaging; 2009; 40(5):453-60. PubMed ID: 19772268
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The natural history of pigment epithelial detachment associated with central serous chorioretinopathy.
    Mudvari SS; Goff MJ; Fu AD; McDonald HR; Johnson RN; Ai E; Jumper JM
    Retina; 2007; 27(9):1168-73. PubMed ID: 18046220
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk factors for recurrence of serous macular detachment in untreated patients with central serous chorioretinopathy.
    Fok AC; Chan PP; Lam DS; Lai TY
    Ophthalmic Res; 2011; 46(3):160-3. PubMed ID: 21389741
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intravitreal ranibizumab for acute central serous chorioretinopathy.
    Kim M; Lee SC; Lee SJ
    Ophthalmologica; 2013; 229(3):152-7. PubMed ID: 23257663
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhanced depth imaging optical coherence tomography of the choroid in central serous chorioretinopathy.
    Imamura Y; Fujiwara T; Margolis R; Spaide RF
    Retina; 2009; 29(10):1469-73. PubMed ID: 19898183
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Longitudinal cohort study of patients with birdshot chorioretinopathy. IV. Visual field results at baseline.
    Gordon LK; Monnet D; Holland GN; Brézin AP; Yu F; Levinson RD
    Am J Ophthalmol; 2007 Dec; 144(6):829-837. PubMed ID: 17937923
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fundus autofluorescence and visual acuity in central serous chorioretinopathy.
    Imamura Y; Fujiwara T; Spaide RF
    Ophthalmology; 2011 Apr; 118(4):700-5. PubMed ID: 21055816
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.